Skip to content
PubMed This is a summary of 44 peer-reviewed journal articles Updated
Gynecology

Cystadenofibroma: A Patient Guide

At a Glance

Cystadenofibroma is a rare, noncancerous ovarian growth that can look like cancer on ultrasound or MRI because of its dense tissue and complex cysts. A tissue examination confirms the diagnosis, and complete removal usually means an excellent long-term outlook.

Discovering that you might have a cystadenofibroma can be a confusing experience, often marked by a sudden transition from routine care to high-stakes medical concern. This rare ovarian growth is defined by a unique biological makeup, containing both fluid-filled sacs (epithelial tissue) and dense, solid “scaffolding” (fibrous stroma). When confirmed by a pathologist, a cystadenofibroma is entirely benign (non-cancerous) [1]. However, its physical structure creates a medical paradox: it often mimics the appearance of cancer on initial imaging tests [2].

For many patients, the journey begins when an ultrasound—often performed for unrelated symptoms or a routine check—identifies a “complex” or “suspicious” mass. Because the dense fibrous parts of a suspected cystadenofibroma can raise concern for aggressive tumor growth, and its cysts can have internal walls or finger-like projections, even advanced risk-calculating tools can sometimes flag these growths as high-risk for malignancy [3][4]. It is normal to feel significant anxiety during this time. However, it is important to remember that this “scare” is often a known characteristic of how this specific tumor’s fibrous tissue interacts with imaging technology, not definitive proof of cancer [4].

Because imaging cannot provide a 100% definitive answer, management depends on the mass’s size, your symptoms, and how suspicious the imaging is. Some small, asymptomatic masses might be monitored with follow-up ultrasounds. However, surgery is often recommended to relieve physical symptoms, prevent the ovary from twisting (torsion), or obtain a definitive diagnosis through pathology when imaging cannot rule out malignancy.

During surgery, doctors often use a “frozen section”—a rapid, mid-operation analysis of the tissue—to help guide their approach. This helps the surgeon tailor the operation, often allowing them to be as conservative as possible and preserve healthy ovarian tissue when the frozen section suggests a benign mass [1][5].

Once a cystadenofibroma is completely removed and confirmed as benign by the final, permanent pathology report, the long-term outlook is excellent. These tumors are considered cured upon removal and do not require chemotherapy, radiation, or the intensive surveillance used for malignant conditions [5]. While the path to this diagnosis can be frightening, the result is a stable, benign finding.

Common questions in this guide

What is an ovarian cystadenofibroma?
An ovarian cystadenofibroma is a rare, noncancerous growth made of fluid-filled sacs and dense supporting tissue. It can look concerning on ultrasound or MRI, so a pathologist often confirms the diagnosis by examining tissue.
Why can cystadenofibroma look like cancer on an ultrasound or MRI?
Its dense fibrous tissue and complex cysts can create solid areas, internal walls, or finger-like projections that appear suspicious on scans. Imaging cannot provide a completely certain diagnosis, so a suspicious appearance does not by itself mean the mass is cancer.
Can a cystadenofibroma be watched instead of removed?
Some small ovarian cystadenofibromas that cause no symptoms may be monitored with follow-up ultrasounds. Surgery may be recommended when the mass is large, causes symptoms, could twist the ovary, or cannot be confidently distinguished from cancer.
What is a frozen section, and why might I need one during surgery?
A frozen section is a rapid examination of tissue during an operation. It can help the surgeon decide how much tissue to remove and may support preserving healthy ovarian tissue when the mass appears benign, while the final permanent report provides the definitive result.
What follow-up is needed after a cystadenofibroma is removed?
If the mass is completely removed and the final pathology confirms it is benign, it is generally considered cured. Chemotherapy, radiation, and the intensive follow-up used for malignant tumors are usually not needed, although your clinician will set follow-up based on your individual surgery and health.

Get notified when new evidence is published on cystadenofibroma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (5)
  1. 1

    A Rare Case of Bilateral Serous Cystadenofibroma in a Malignant Disguise.

    Ansari SA, AlSindi K, Aldoseri F

    The Gulf journal of oncology 2022; (1(40)):67-70.

    PMID: 36448072
  2. 2

    Serous ovarian cystadenofibroma and review of the literature: Report of a case.

    Bencherifi Y, Watik F, Lyafi Y, et al.

    International journal of surgery case reports 2023; (110()):108649 doi:10.1016/j.ijscr.2023.108649.

    PMID: 37639968
  3. 3

    Benign serous cystadenofibroma with multimodal imaging suggestive of malignancy in a symptomatic postmenopausal patient.

    Palisciano M, Terrinoni M, Napoleoni E, et al.

    Przeglad menopauzalny = Menopause review 2025; (24(3)):221-224 doi:10.5114/pm.2025.154684.

    PMID: 41114411
  4. 4

    Pearls and Potential Pitfalls for Correct Diagnosis of Ovarian Cystadenofibroma in MRI: A Pictorial Essay.

    Avesani G, Caliolo G, Gui B, et al.

    Korean journal of radiology 2021; (22(11)):1809-1821 doi:10.3348/kjr.2020.1312.

    PMID: 34668348
  5. 5

    Omental Serous Cystadenofibroma Mimicking Disseminated Malignancy: A Rare Pathology.

    Ezeibe C, Walwyn-Tross L, Perisic D

    Journal of medical cases 2026; (17(6)):292-295 doi:10.14740/jmc5316.

    PMID: 42146030

This page is for informational purposes only and does not constitute medical advice. Your gynecologic care team should interpret your imaging and pathology and recommend follow-up for your specific situation.